Published in Clin Vaccine Immunol on January 30, 2013
Host immunity to Cryptococcus neoformans. Future Microbiol (2015) 0.85
Innate Defense against Fungal Pathogens. Cold Spring Harb Perspect Med (2014) 0.82
The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB. Elife (2016) 0.79
Candida albicans Induces Metabolic Reprogramming in Human NK Cells and Responds to Perforin with a Zinc Depletion Response. Front Microbiol (2016) 0.78
Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility. Genes Immun (2015) 0.76
Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells. J Virol (2016) 0.76
Pollution of mycological surfaces in hospital emergency departments correlates positively with blood NKT CD3(+) 16(+) 56(+) and negatively with CD4(+) cell levels of their staff. Cent Eur J Immunol (2016) 0.75
Aspergillus fumigatus responds to natural killer (NK) cells with upregulation of stress related genes and inhibits the immunoregulatory function of NK cells. Oncotarget (2016) 0.75
Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy. AIDS (2016) 0.75
First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis. Front Microbiol (2016) 0.75
Granule-Dependent Natural Killer Cell Cytotoxicity to Fungal Pathogens. Front Immunol (2017) 0.75
NK cell recognition. Annu Rev Immunol (2005) 14.40
Cellular responses to interferon-gamma. Annu Rev Immunol (1997) 13.23
The biology of human natural killer-cell subsets. Trends Immunol (2001) 10.10
Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest (2006) 4.45
Immunity to fungal infections. Nat Rev Immunol (2011) 4.33
The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol (1982) 3.92
Immunity to fungal infections. Nat Rev Immunol (2004) 3.58
Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature (2009) 3.07
Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol (2002) 2.68
Cytotoxicity of activated natural killer cells against pediatric solid tumors. Clin Cancer Res (2010) 2.51
Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect (2002) 2.43
Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor. Proc Natl Acad Sci U S A (2007) 2.34
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood (2005) 2.31
The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature (2010) 2.23
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A (2004) 2.23
In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. J Immunol (1982) 2.19
Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol (2003) 2.08
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med (2012) 1.86
Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc Natl Acad Sci U S A (1984) 1.74
Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood (2004) 1.71
Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun (1997) 1.71
Natural killer cells in human health and disease. Clin Immunol (2005) 1.68
Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med (2002) 1.68
Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis (2010) 1.66
Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest (2003) 1.62
Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans. Infect Immun (1986) 1.61
Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood (2004) 1.51
The effect of gliotoxin upon macrophage function. Int J Immunopharmacol (1986) 1.50
Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest (1993) 1.50
What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol (2010) 1.48
Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect Immun (1991) 1.48
Purified perforin induces target cell lysis but not DNA fragmentation. J Exp Med (1989) 1.47
Natural cellular resistance of beige mice against Cryptococcus neoformans. J Immunol (1986) 1.44
Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br J Haematol (2004) 1.42
Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells. Infect Immun (1986) 1.41
A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe (2011) 1.41
Granulysin, a T cell product, kills bacteria by altering membrane permeability. J Immunol (2000) 1.39
Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J Clin Invest (1993) 1.38
Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. Am J Pathol (1987) 1.34
Host-microbe interactions: innate pattern recognition of fungal pathogens. Curr Opin Microbiol (2008) 1.33
Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun (1994) 1.31
Natural killer cell clones can efficiently process and present protein antigens. J Immunol (1991) 1.28
Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun (2004) 1.27
Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol (1998) 1.23
Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int Immunol (2002) 1.23
Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol (2009) 1.22
Aspergillus fumigatus conidial melanin modulates host cytokine response. Immunobiology (2009) 1.21
NK cells use perforin rather than granulysin for anticryptococcal activity. J Immunol (2004) 1.20
IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J Immunol (2000) 1.17
NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J Immunol (2008) 1.17
A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol (2001) 1.11
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion. J Immunother (2010) 1.11
In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase. Infect Immun (1984) 1.07
Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol (2005) 1.07
Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-to-chemokine amplification loop. J Immunol (2010) 1.06
Two-step negative enrichment of CD4+ and CD8+ T cells from murine spleen via nylon wool adherence and an optimized antibody cocktail. J Immunol Methods (2001) 1.04
Yeast apoptosis--from genes to pathways. Semin Cancer Biol (2006) 1.04
Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. Cell Immunol (1998) 1.03
Biology and clinical relevance of granulysin. Tissue Antigens (2009) 1.03
Cytoplasmic components of natural killer cells limit the growth of Cryptococcus neoformans. J Leukoc Biol (1990) 1.01
NK cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18. Microbiol Immunol (2000) 1.00
Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release. J Immunol (2011) 1.00
Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol (1993) 1.00
IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol (1995) 0.99
Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. Infect Immun (1997) 0.99
Recalcitrant trichophytic granuloma associated with NK-cell deficiency in a SLE patient treated with corticosteroid. Eur J Dermatol (2001) 0.97
FimH can directly activate human and murine natural killer cells via TLR4. Mol Ther (2010) 0.97
Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity. Infect Immun (2009) 0.96
The fungal metabolite gliotoxin: immunosuppressive activity on CTL-mediated cytotoxicity. Immunol Lett (2000) 0.95
NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms. Infect Immun (2004) 0.94
Natural killer cells: role in local tumor growth and metastasis. Biologics (2012) 0.94
CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis. J Immunol (2009) 0.92
Insights into NK cell biology from human genetics and disease associations. Cell Mol Life Sci (2011) 0.90
Function and Regulation of Natural Killer (NK) Cells during Viral Infections: Characterization of Responses in Vivo Methods (1996) 0.90
Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. FEMS Immunol Med Microbiol (2002) 0.89
Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence. Clin Microbiol Infect (2006) 0.88
Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity. Immunobiology (2012) 0.88
Anticryptococcal activity of NK cell-enriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: responses to interleukin-2, interferon-gamma, and interleukin-12. J Infect Dis (1995) 0.86
Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma. Front Pharmacol (2012) 0.86
Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med Mycol (2001) 0.85
DEteCTINg fungal pathogens. Nat Immunol (2007) 0.84
Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils. J Med Vet Mycol (1992) 0.83
Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cells. Infect Immun (2006) 0.83
Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferation. Cytokine (1993) 0.83
Perforin is required for primary immunity to Histoplasma capsulatum. J Immunol (2001) 0.82
Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicans. Cell Immunol (1998) 0.82
Low natural killer cell function in disseminated aspergillosis. Scand J Infect Dis (1993) 0.78
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C. albicans hyphae in vitro. J Gen Microbiol (1991) 0.77
Interleukin-2 and increased natural killer activity in mice experimentally infected with Aspergillus niger. Microbiologica (1988) 0.76
Immune responses in histoplasmosis, a prototype of respiratory mycoses. Indian J Chest Dis Allied Sci (2004) 0.76
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med (2006) 9.68
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med (2010) 4.76
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood (2012) 2.39
Targeted cell entry of lentiviral vectors. Mol Ther (2008) 2.34
Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol (2006) 1.82
Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol (2004) 1.76
Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis (2010) 1.66
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Pediatr Infect Dis J (2010) 1.66
111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med (2004) 1.53
Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat Methods (2010) 1.48
Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci U S A (2006) 1.48
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica (2010) 1.30
Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood (2005) 1.28
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood (2013) 1.23
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group. Blood (2013) 1.21
IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA. Eur J Immunol (2010) 1.20
Treatment of patients with advanced cancer with the natural killer cell line NK-92. Cytotherapy (2013) 1.17
Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples. Blood (2011) 1.17
Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer (2007) 1.16
NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin. J Cell Mol Med (2012) 1.16
Age-matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis. Eur J Haematol (2008) 1.15
Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol (2006) 1.13
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion. J Immunother (2010) 1.11
Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J (2012) 1.09
Activation of Epac stimulates integrin-dependent homing of progenitor cells. Blood (2007) 1.09
Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency. Pediatr Res (2006) 1.05
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells. Cytotherapy (2011) 1.04
More than mere games: a review of card and board games for medical education. Med Teach (2007) 1.02
Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia. PLoS One (2012) 1.02
An improved bicistronic CD20/tCD34 vector for efficient purification and in vivo depletion of gene-modified T cells for adoptive immunotherapy. Mol Ther (2010) 1.00
Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med (2012) 0.97
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol. Front Oncol (2013) 0.97
IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study. PLoS One (2011) 0.97
Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation. Transfusion (2009) 0.95
Fluoroquinolones in children with fever and neutropenia: a systematic review of prospective trials. Pediatr Infect Dis J (2012) 0.94
Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse. J Clin Oncol (2010) 0.94
Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis. Ann Rheum Dis (2007) 0.93
Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance. J Innate Immun (2011) 0.93
Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases. Mycoses (2011) 0.92
Human herpes virus-6 DNA in cerebrospinal fluid of children undergoing therapy for acute leukaemia. Br J Haematol (2008) 0.91
Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing. Curr Gene Ther (2015) 0.91
Infections in pediatric acute myeloid leukemia: lessons learned and unresolved questions. Pediatr Blood Cancer (2008) 0.90
Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. PLoS Pathog (2010) 0.90
A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells. J Immunol Methods (2004) 0.89
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium. J Clin Oncol (2013) 0.89
Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity. Immunobiology (2012) 0.88
A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells. J Immunol Methods (2007) 0.88
Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel. Pediatr Blood Cancer (2014) 0.87
Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood. J Immunol Methods (2008) 0.86
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation. PLoS One (2012) 0.85
Immunosenescence-associated microRNAs in age and heart failure. Eur J Heart Fail (2012) 0.85
Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis. Br J Haematol (2013) 0.84
A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia. Pediatr Infect Dis J (2012) 0.84
Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey. J Antimicrob Chemother (2006) 0.83
Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy. Cancer Immunol Immunother (2014) 0.83
The reporting of outcomes in studies of fever and neutropenia in children with cancer: time for consensus. Pediatr Blood Cancer (2013) 0.83
Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes. Cytotherapy (2013) 0.83
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients. Cancer Chemother Pharmacol (2008) 0.82
Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia. Br J Haematol (2009) 0.82
The hedgehog inhibitor cyclopamine induces apoptosis in leukemic cells in vitro. Leuk Lymphoma (2008) 0.82
Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells. Best Pract Res Clin Haematol (2011) 0.82
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach. Ann Hematol (2015) 0.81
Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis. Pediatr Infect Dis J (2003) 0.81
MR spectroscopy differentiation between high and low grade astrocytomas: a comparison between paediatric and adult tumours. Eur J Paediatr Neurol (2010) 0.81
Failure of interferon gamma to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis. PLoS One (2010) 0.81
Immunotherapy in invasive fungal infection--focus on invasive aspergillosis. Curr Pharm Des (2013) 0.81
Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies. Lancet Oncol (2008) 0.81
Immunotherapy against invasive fungal diseases in stem cell transplant recipients. Immunol Invest (2011) 0.80
Posaconazole for paediatric patients: status of development and future perspectives. Mycoses (2008) 0.80
Long-term survival in patients with acute leukemia and chronic disseminated candidiasis despite minimal antileukemic therapy. Haematologica (2006) 0.79
Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse. J Immunol Methods (2011) 0.79
Characterization of the cellular immune responses to Rhizopus oryzae with potential impact on immunotherapeutic strategies in hematopoietic stem cell transplantation. J Infect Dis (2012) 0.79
Rhinocerebral zygomycosis in a young girl undergoing allogeneic stem cell transplantation for severe aplastic anaemia. Mycoses (2006) 0.79
Safety experience with caspofungin in pediatric patients. Pediatr Infect Dis J (2009) 0.79
Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant. J Infect Dis (2007) 0.78
Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: a systematic review. Support Care Cancer (2012) 0.78
Cultivated anti-Aspergillus T(H)1 cells. Med Mycol (2008) 0.78
The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC). J Immunother (2009) 0.77